Control of nose bleeds in hereditary haemorrhagic telangiectasia.
D000328:Adult; D004844:Epistaxis / Q000209:etiology / Q000517:prevention & control*; D004967:Estrogens / Q000627:therapeutic use*; D004997:Ethinyl Estradiol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008234:Lynestrenol / Q000627:therapeutic use; D008297:Male; D008656:Mestranol / Q000627:therapeutic use; D008777:Methyltestosterone / Q000627:therapeutic use; D011374:Progesterone / Q000627:therapeutic use*; D013683:Telangiectasia, Hereditary Hemorrhagic / Q000150:complications*
D004967:Estrogens; D004997:Ethinyl Estradiol; D011374:Progesterone; D008656:Mestranol; D008234:Lynestrenol; D008777:Methyltestosterone